Page 161 - 2019_06-Haematologica-web
P. 161

Glycoprotein V in ITP
cytopenia. Thromb Haemost. 2013;
110(6):1259-1266.
25. McMillan R. The pathogenesis of chronic
immune thrombocytopenic purpura.
Semin Hematol. 2007;44(4 Suppl 5):S3-S11.
26. Beardsley DS, Ertem M. Platelet autoanti- bodies in immune thrombocytopenic pur-
pura. Transfus Sci. 1998;19(3):237-244.
27. He R, Reid DM, Jones CE, Shulman NR. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura.
Blood. 1994;83(4):1024-1032.
28. Kiefel V, Freitag E, Kroll H, Santoso S,
Mueller-Eckhardt C. Platelet autoantibod- ies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombo- cytopenia. Ann Hematol. 1996;72(4):280- 285.
29. Kong X, Ye B, Yang Z, Chen B, Ling Y. Simultaneous detection of platelet-specific antibodies based on a photonic crystal- encoded suspension array. Clin Chim Acta. 2016;458:72-77.
30. Kapur R, Heitink-Pollé KM, Porcelijn L, et al. C-reactive protein enhances IgG mediat- ed phagocyte responses and thrombocy- topenia. Blood. 2015;125(11):1793-1802.
31. Berndt MC, Phillips DR. Interaction of thrombin with platelets: purification of the thrombin substrate. Ann N Y Sci 1981; 370:87-95.
32. RabieT, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem. 2005;280(15):14462-14468.
33. Ramakrishnan V, Reeves PS, DeGuzman F. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci U S A. 1999; 96(23):13336-13341.
34. Ni H, Ramakrishnan V, Ruggeri ZM, Papalia JM, Phillips DR, Wagner DD. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood. 2001;98(2):368-373.
35. Zeng Q, Zhu L, Tao L, et al. Relative effica- cy of steroid therapy in immune thrombo-
cytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies. Am J Hematol. 2012;87(2):206-208.
36. PengJ,MaSH,LiuJ,HouY,etal. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. J Thromb Haemost. 2014;12(4):497-504.
37. Hurlimann-Forster M, Steiner B, von Felten A. Quantitation of platelet-specific autoan- tibodies in platelet eluates of ITP patients measured by a novel ELISA using the puri- fied glycoprotein complexes GPIIb/IIIa and GPIb/IX as antigens. Br J Haematol. 1997;98(2):328-335.
38. Chan H, Moore JC, Finch CN, Warkentin TE, Kelton JG. The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura. Br J Haematol. 2003;122(5):818- 824.
haematologica | 2019; 104(6)
1243


































































































   159   160   161   162   163